| Literature DB >> 35813705 |
Till J Demal1, Franziska W Sitzmann1, Lennart Bax1, Yskert von Kodolitsch2, Jens Brickwedel1, Johanna Konertz1, Daniel M Gaekel1, Ahmed J Sadeq1, Tilo Kölbel2, Eik Vettorazzi3, Hermann Reichenspurner1, Christian Detter1.
Abstract
Background: We aimed to identify risk factors for an impaired postoperative neurological outcome after thoracic aortic surgery.Entities:
Keywords: Thoracic aortic surgery; acute type A dissection (ATAD); aortic arch surgery; risk factors; stroke
Year: 2022 PMID: 35813705 PMCID: PMC9264055 DOI: 10.21037/jtd-21-1591
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 3.005
Baseline characteristics
| Characteristics | All (n=1,334) | No stroke (n=1,240) | Stroke (n=94) | P value |
|---|---|---|---|---|
| Age (years), mean ± SD | 61.4±14.2 | 61.0±14.3 | 67.2±11.5 | <0.001 |
| Female gender, n (%) | 466 (34.9) | 434 (35.0) | 32 (34.0) | 0.851 |
| Obesity (BMI >35 kg/m²), n (%) | 81 (6.1) | 79 (6.4) | 2 (2.1) | 0.097 |
| Arterial hypertension, n (%) | 1,040 (78.0) | 958 (77.3) | 82 (87.2) | 0.024 |
| Any atherosclerotic entity, n (%) | 493 (37.0) | 445 (35.9) | 48 (51.1) | 0.003 |
| Coronary artery disease | 380 (28.5) | 341 (27.5) | 39 (41.5) | 0.004 |
| Extracardiac arteriopathy | 184 (13.8) | 164 (13.2) | 20 (21.3) | 0.029 |
| Atrial fibrillation, n (%) | 209 (15.7) | 192 (15.5) | 17 (18.1) | 0.504 |
| IDDM, n (%) | 31 (2.3) | 28 (2.3) | 3 (3.2) | 0.476 |
| Chronic lung disease, n (%) | 134 (10.0) | 117 (9.4) | 17 (18.1) | 0.007 |
| Smoker, n (%) | 525 (39.4) | 484 (39.0) | 41 (43.6) | 0.380 |
| Chronic kidney disease, n (%) | 256 (19.2) | 224 (18.1) | 32 (34.0) | <0.001 |
| Previous cardiac surgery, n (%) | 136 (10.2) | 126 (10.2) | 10 (10.6) | 0.883 |
| EuroSCORE II, mean ± SD | 8.6±10.1 | 8.1±9.5 | 15.0±13.9 | <0.001 |
| Preoperative stroke, n (%) | 114 (8.5) | 103 (8.3) | 11 (11.7) | 0.256 |
| Linked to aortic syndrome | 34 (2.5) | 33 (2.7) | 1 (1.1) | 0.508 |
| Not linked to aortic syndrome | 80 (6.0) | 70 (5.6) | 10 (10.6) | 0.049 |
| Preoperative critical state, n (%) | 134 (10.0) | 110 (8.9) | 24 (25.5) | <0.001 |
| Preoperative cerebral malperfusion, n (%) | 56 (4.2) | 44 (3.5) | 12 (12.8) | <0.001 |
| Genetic aortic syndrome, n (%) | 123 (9.2) | 121 (9.8) | 2 (2.1) | 0.014 |
| Malfunction or infection of TEVAR or aortic graft, n (%) | 14 (1.0) | 11 (0.9) | 3 (3.2) | 0.070 |
| Aneurysm, n (%) | 948 (71.1) | 914 (73.7) | 34 (36.2) | <0.001 |
| ATAD, n (%) | 240 (18.0) | 202 (16.3) | 38 (40.4) | <0.001 |
| IMH, n (%) | 43 (3.2) | 36 (2.9) | 7 (7.4) | 0.027 |
| PAU, n (%) | 13 (1.0) | 11 (0.9) | 2 (2.1) | 0.232 |
| Chronic dissection, n (%) | 56 (4.5) | 61 (4.6) | 5 (5.3) | 0.613 |
| Aortic rupture, n (%) | 68 (5.1) | 56 (4.5) | 12 (12.8) | 0.002 |
| Maximum thoracic aortic diameter (mm), mean ± SD | 5.49±1.18 | 5.49±1.19 | 5.45±1.09 | 0.766 |
| Urgency status, n (%) | ||||
| Elective | 999 (74.9) | 960 (77.4) | 39 (41.5) | <0.001 |
| Urgent | 47 (3.5) | 42 (3.4) | 5 (5.3) | 0.375 |
| Emergent or salvage | 286 (21.4) | 236 (19.0) | 50 (53.2) | <0.001 |
SD, standard deviation; BMI, body mass index; IDDM, insulin-dependent diabetes mellitus; TEVAR, thoracic endovascular aortic repair; ATAD, acute type A dissection; IMH, intramural hematoma; PAU, penetrating atherosclerotic ulcer.
Figure 1Postoperative stroke rate in different surgical procedures. The postoperative stroke rate differs between specific aortic procedures. While the stroke rate for elective valve-sparing root replacement and ascending replacement with or without concomitant AVR without HCA is as low as 0.5% and 1.5%, respectively, the rate after elective aortic arch surgery is as high as 10.7%. In urgent, elective or emergent procedures, the stroke rate is higher. In isolated ascending replacement, the stroke rate is 0%. AVR, aortic valve replacement; HCA, hypothermic circulatory arrest.
Surgical procedures
| Procedures | All (n=1,334) | No stroke (n=1,240) | Stroke (n=94) | P value |
|---|---|---|---|---|
| Aortic root surgery, n (%) | 451 (33.8) | 431 (34.8) | 20 (21.3) | 0.008 |
| Bentall procedure | 230 (17.2) | 214 (17.3) | 16 (17.0) | 0.953 |
| Valve-sparing root replacement | 221 (16.6) | 217 (17.5) | 4 (4.3) | 0.001 |
| Isolated ascending replacement, n (%) | 82 (6.1) | 80 (6.5) | 2 (2.1) | 0.092 |
| Wheat (supracoronary + AVR), n (%) | 251 (18.8) | 241 (19.4) | 10 (10.6) | 0.035 |
| Arch procedure, n (%) | 622 (46.6) | 446 (44.0) | 76 (80.9) | <0.001 |
| Hemiarch | 419 (31.4) | 365 (29.4) | 54 (57.4) | <0.001 |
| Total arch | 203 (15.2) | 181 (14.6) | 22 (23.4) | 0.022 |
| Conventional | 69 (5.2) | 61 (4.9) | 8 (8.5) | 0.143 |
| FET | 134 (10.0) | 120 (9.7) | 14 (14.9) | 0.105 |
| Simplified FET technique | 70 (5.2) | 67 (5.4) | 3 (3.2) | 0.475 |
| Descending procedure, n (%) | 9 (0.7) | 8 (0.6) | 1 (1.1) | 0.483 |
| Concomitant surgery, n (%) | ||||
| CABG | 193 (14.5) | 169 (13.6) | 24 (25.5) | 0.002 |
| TVR | 21 (1.6) | 20 (1.6) | 1 (1.1) | >0.990 |
| MVR | 58 (4.3) | 55 (4.4) | 3 (3.2) | 0.793 |
| VAD implantation | 2 (0.1) | 2 (0.2) | 0 (0.0) | >0.990 |
AVR, aortic valve replacement; FET, frozen elephant trunk; CABG, coronary artery bypass grafting; TVR, tricuspid valve replacement; MVR, mitral valve repair; VAD, ventricular assist device.
Intraoperative data
| Intraoperative data | All (n=1,334) | No stroke (n=1,240) | Stroke (n=94) | P value |
|---|---|---|---|---|
| Aortic surgeon (>20 aortic procedures per year), n (%) | 771 (57.8) | 721 (58.2) | 50 (53.2) | 0.344 |
| Time of surgery, n (%) | ||||
| Weekend surgery | 63 (4.7) | 52 (4.2) | 11 (11.7) | 0.003 |
| Night-time surgery | 197 (14.8) | 165 (13.3) | 32 (34.0) | <0.001 |
| ECC time (min), mean ± SD | 185.9±79.8 | 181.6±76.3 | 242.3±101.5 | <0.001 |
| Aortic clamp time (min), mean ± SD | 105.3±50.5 | 104.6±49.6 | 115.3±61.3 | 0.108 |
| HCA with SACP, n (%) | 530 (39.7) | 466 (37.6) | 64 (68.1) | <0.001 |
| Unilateral CP, n (%) | 53 (4.1) | 46 (3.8) | 7 (7.8) | 0.087 |
| Bilateral CP, n (%) | 546 (41.7) | 481 (39.5) | 65 (72.2) | <0.001 |
| Cerebral hypothermic arrest, n (%) | 19 (1.5) | 18 (1.5) | 1 (1.1) | 1.000 |
| CP flow (mL/min), mean ± SD | 1,240.8±425.8 | 1,240.5±435.4 | 1,242.4±353.7 | 0.973 |
| CP volume (liter), mean ± SD | 58.1±54.5 | 57.5±53.8 | 62.9±59.4 | 0.465 |
| CP temperature (℃), mean ± SD | 22.4±4.5 | 22.5±4.6 | 21.8±3.2 | 0.215 |
| Cerebral monitoring, n (%) | 576 (49.1) | 515 (47.2) | 61 (73.5) | <0.001 |
| Circulatory arrest time (min), mean ± SD | 36.8±25.3 | 36.1±24.7 | 41.6±29.5 | 0.082 |
| CP time (min), mean ± SD | 41.6±31.7 | 40.9±31.0 | 46.4±36.1 | 0.158 |
| Deepest body temperature (℃), mean ± SD | 28.7±4.0 | 28.9±4.0 | 25.9±3.5 | <0.001 |
| Site of arterial cannulation, n (%) | ||||
| Ascending aorta or aortic arch | 903 (67.7) | 857 (69.1) | 46 (48.9) | <0.001 |
| Innominate artery | 182 (13.6) | 169 (13.6) | 13 (13.8) | 0.956 |
| Subclavian artery | 211 (15.8) | 181 (14.6) | 30 (31.9) | <0.001 |
| Femoral artery | 34 (2.5) | 29 (2.3) | 5 (5.3) | 0.085 |
ECC, extracorporeal circulation; SD, standard deviation; HCA, hypothermic circulatory arrest; SACP, selective antegrade cerebral perfusion; CP, cerebral perfusion.
Outcome parameters
| Parameters | All (n=1,334) | No stroke (n=1,240) | Stroke (n=94) | P value |
|---|---|---|---|---|
| In-hospital/30-day mortality, n (%) | 79 (5.9) | 47 (3.8) | 32 (34.0) | <0.001 |
| One-year mortality, n (%) | 106 (17.8) | 65 (12.2) | 41 (65.1) | <0.001 |
| Transient ND, n (%) | 34 (2.5) | 34 (2.7) | – | – |
| Resternotomy for bleeding or tamponade, n (%) | 139 (10.4) | 116 (9.4) | 23 (24.5) | <0.001 |
| Reanimation or shock, n (%) | 77 (5.8) | 59 (4.8) | 18 (19.1) | <0.001 |
| Paraplegia, n (%) | 14 (1.0) | 9 (0.7) | 5 (5.3) | 0.002 |
| Recurrent nerve palsy, n (%) | 29 (2.2) | 27 (2.2) | 2 (2.1) | >0.999 |
| Pneumonia or other respiratory insufficiency, n (%) | 174 (13.0) | 143 (11.5) | 31 (33.0) | <0.001 |
| Sepsis, n (%) | 30 (2.2) | 18 (1.5) | 12 (12.8) | <0.001 |
| New-onset atrial fibrillation, n (%) | 265 (19.9) | 243 (19.6) | 22 (23.4) | 0.372 |
| Myocardial infarction, n (%) | 10 (0.7) | 9 (0.7) | 1 (1.1) | 0.520 |
ND, neurological deficit.
Risk factors for stroke after thoracic aortic surgery
| Risk factors | OR | 95% CI | P value |
|---|---|---|---|
| Advanced age (>70 years) | 1.83 | 1.16–2.88 | 0.009 |
| Arterial hypertension | – | – | 0.662 |
| Any atherosclerotic entity | – | – | 0.397 |
| Chronic kidney disease | – | – | 0.061 |
| History of cerebrovascular accident | – | – | 0.230 |
| Preoperative cerebral malperfusion | – | – | 0.126 |
| Preoperative critical state | – | – | 0.101 |
| ATAD | 1.69 | 1.00–2.84 | 0.0495 |
| Aortic rupture | – | – | 0.096 |
| Aortic surgeon | – | – | 0.421 |
| Weekend surgery | – | – | 0.300 |
| Night-time surgery | – | – | 0.200 |
| Valve-sparing root replacement | – | – | 0.071 |
| Aortic arch surgery | 3.24 | 1.78–5.88 | <0.001 |
| FET | – | – | 0.315 |
| Concomitant CABG | 2.19 | 1.27–3.79 | 0.005 |
| High ECC time (>230 min) | 1.70 | 1.04–2.77 | 0.034 |
| High aortic clamp time (>155 min) | – | – | 0.479 |
| HCA with SACP | – | – | 0.843 |
| High circulatory arrest time (>60 min) | – | – | 0.752 |
| High CP time (>90 min) | – | – | 0.235 |
| Low body temperature (<25 ℃) | – | – | 0.286 |
| Site of arterial cannulation | |||
| Ascending aorta or aortic arch | – | – | 0.512 |
| Innominate artery | – | – | 0.114 |
| Subclavian artery | – | – | 0.121 |
| Femoral artery | – | – | 0.123 |
P value of acute type A dissection is reported with 4 decimals to show significance. ATAD, acute type A dissection; FET, frozen elephant trunk; CABG, coronary artery bypass grafting; ECC, extracorporeal circulation; HCA, hypothermic circulatory arrest; SACP, selective antegrade cerebral perfusion; CP, cerebral perfusion; OR, odds ratio; CI, confidence interval.
Figure 2Kaplan-Meier overall, 30-, and 90-day landmark survival analyses. Long-term survival was compared between the stroke and no stroke group using Cox regression analysis adjusting for known risk factors for mortality after aortic surgery (age, gender, peripheral arterial disease, ejection fraction under 30%, chronic lung disease, renal function, preoperative critical state, ATAD, and high ECC time). Survival in stroke patients was significantly lower than in patients without postoperative stroke in the overall cohort (A) and in the 30-day landmark analysis (B). Overall mean survival was 45.8 (95% CI, 32.9–58.7) months in the stroke group vs. 107.0 (95% CI, 103.4–110.6) months in the no stroke group. Mean survival in the 30-day landmark analysis was 69.4 (95% CI, 52.6–86.2) months in the stroke and 111.2 (95% CI, 107.7–114.7) months in the no stroke group. Contrary, survival did not show a statistically significant difference between groups in the 90-day landmark Cox regression analysis anymore (C). In the 90-day landmark analysis mean survival was 80.8 (95% CI, 63.4–98.1) months in the stroke and 111.9 (95% CI, 108.5–115.4) months in the no stroke group. HR, hazard ratio; CI, confidence interval; ATAD, acute type A dissection; ECC, extracorporeal circulation.